Learn more about whether Nurix Therapeutics, Inc. or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Former Google CEO Eric Schmidt expressed astonishment at AI's rapid progress, particularly its ability to autonomously ...

Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...

Anthropic's chief scientist Jared Kaplan says humanity will soon have a big decision to make on whether to take the "ultimate ...

With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect of the process, including the improvement of AI coding tools themselves.

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

In the race to build increasingly autonomous AI agents, the community has focused heavily on improving agents’ capabilities ...

In this essay by Edgar Calabia Samar, he shows how Eka Kurniawan’s 'Beauty Is a Wound' teaches us to dream at multiple scales ...

Viewed this way, a definition is a decision mechanism. It distinguishes some elements of the universe from the others. Hence ...